n.a. (PVA: NYSE)
$n/a n/a | n/a%
12/31/69 - 07:00 PM ET
TheStreet Ratings Grade for PVA
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings data is not available for PVA.
Portfolios with PVA
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorNatural Gas Stock Trades Th...
- UserThe First One
- Contributor7 Marcellus Shale Plays to ...
- Contributor9 Marcellus Shale Stocks Wi...
- Contributor10 Small-Caps Expected to R...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Research Reports 8...
- UserBarrons Interview With Jim ...
Latest PVA Headlines from TheStreet
- Penn Virginia (PVA) Stock Closes Higher on Rising Oil Prices 08.28.15 | 04:08 pm
- 6 Stocks Under $10 to Trade for Breakouts 08.27.15 | 01:08 pm
- Penn Virginia (PVA) Stock Gets Rating Downgrade at Credit Suisse 08.07.15 | 01:08 pm
- Penn Virginia Corporation Engages Jefferies LLC As Exclusive Financial Advisor For Certain Eagle Ford-Related Transactions 08.04.15 | 10:08 am
- Penn Virginia (PVA) Stock Falls as Oil Prices Tumble 08.03.15 | 12:08 pm
- Penn Virginia (PVA) Stock Closes Down as Oil Prices Fall 07.31.15 | 04:07 pm
- Penn Virginia Corporation Announces Second Quarter 2015 Results And Provides Updates Of 2015 Guidance And Operations 07.29.15 | 04:07 pm
- Penn Virginia (PVA) Stock Higher Amid Rally in Oil Prices 07.29.15 | 02:07 pm
- Penn Virginia (PVA) Showing Signs Of A Dead Cat Bounce Today 07.23.15 | 09:07 am
- Penn Virginia Corporation Chief Executive Officer And President Baird Whitehead Announces Retirement; Board Commences Chief Executive Officer Search 07.20.15 | 04:07 pm
Press Releases for PVA
- PSivida CEO To Speak At Controlled Release Society Annual Meeting Workshop In Edinburgh, Scotland, This Weekend - Business Wire 07.21.15 | 08:07 am
- PSivida Announces Positive Top Line Results From Investigator-Sponsored Phase II Study Of Medidur™ For Uveitis - Business Wire 07.13.15 | 07:07 am
- PSivida Announces Top-Line Results From Investigator-Sponsored Phase II Study Of Medidur™ For Uveitis To Be Reported Next Week - Business Wire 07.07.15 | 11:07 am
- Lone Star Value Calls On Penn Virginia To Launch A Robust Strategic Alternatives Review Process And Fully Explore All Credible Proposals - PR Newswire 06.26.15 | 01:06 pm
- PSivida CEO To Present At ISOPT Clinical Meeting In Berlin In July 2015 - Business Wire 06.24.15 | 07:06 am
- PSivida Reports Positive IOP Safety Data In Phase III Trial Of Medidur™ For Posterior Uveitis - Business Wire 05.19.15 | 07:05 am
- PSivida Announces Two Tech Evaluation Agreements With Leading Global Pharmaceutical Company - Business Wire 05.12.15 | 07:05 am
- PSivida Corp. Reports Third Quarter FY 2015 Results - Business Wire 05.08.15 | 07:05 am
- PSivida Corp. Announces Third Quarter Fiscal Year 2015 Financial Results Release Date And Conference Call Information - Business Wire 05.01.15 | 08:05 am
- PSivida Corp. Reports ILUVIEN® For DME Approved In Poland - Business Wire 04.14.15 | 08:04 am
Partner Headlines for PVA
- Penn Virginia downgraded to Hold from Buy at Canaccord - The Fly 11.11.15 | 06:11 am
- Penn Virginia downgraded to Hold from Buy at KLR Group - The Fly 10.15.15 | 08:10 am
- Penn Virginia downgraded to Underweight from Equalweight at Capital One - The Fly 09.09.15 | 09:09 am
- Penn Virginia downgraded to Neutral from Outperform at Credit Suisse - The Fly 08.07.15 | 07:08 am
- Penn Virginia price target lowered to $3.75 from $8.50 at Canaccord - The Fly 08.03.15 | 07:08 am
- Penn Virginia downgraded to Sector Perform from Outperform at Scotia - The Fly 07.30.15 | 09:07 am
- Soros Left in Lurch as Penn Virginia Misses Window: Real M&A - Bloomberg 07.22.15 | 06:07 pm
- Penn Virginia stock should outperform on asset sale, says SunTrust - The Fly 07.16.15 | 07:07 am
- Penn Virginia downgraded to In-Line from Outperform at Imperial Capital - The Fly 07.15.15 | 05:07 am
- Penn Virginia says seeing interest in East Texas assets, says RBC Capital - The Fly 06.12.15 | 08:06 am